torcetrapib has been researched along with Hyperlipidemias in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (66.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellanger, N; Chapman, MJ; Duchene, E; El Khoury, P; Fournier, N; Guerin, M; Julia, Z; Le Goff, W; Villard, EF | 1 |
| Ghosh, RK; Ghosh, SM | 1 |
| Boekholdt, SM; Hovingh, GK; Kastelein, JJ; Klerkx, AH; Kuivenhoven, JA; van der Steeg, WA | 1 |
| Ansell, BJ | 1 |
| Athyros, VG; Kakafika, A; Karagiannis, A; Mikhailidis, DP; Tziomalos, K | 1 |
3 review(s) available for torcetrapib and Hyperlipidemias
| Article | Year |
|---|---|
Current status of CETP inhibitors in the treatment of hyperlipidemia: an update.
Topics: Amides; Animals; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Esters; Humans; Hyperlipidemias; Oxazolidinones; Quinolines; Risk Factors; Sulfhydryl Compounds | 2012 |
Role of CETP inhibitors in the treatment of dyslipidemia.
Topics: Amides; Animals; Arteriosclerosis; Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Esters; Glycoproteins; Humans; Hyperlipidemias; Hypolipidemic Agents; Quinolines; Sulfhydryl Compounds | 2004 |
Rationale for combination therapy with statin drugs in the treatment of dyslipidemia.
Topics: Anion Exchange Resins; Antihypertensive Agents; Azetidines; Benzenesulfonates; Clofibric Acid; Drug Therapy, Combination; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypoglycemic Agents; Hypolipidemic Agents; Niacin; Quinolines | 2005 |
3 other study(ies) available for torcetrapib and Hyperlipidemias
| Article | Year |
|---|---|
Functionality of postprandial larger HDL2 particles is enhanced following CETP inhibition therapy.
Topics: Adult; Animals; Apolipoprotein A-I; Apolipoprotein A-II; Atorvastatin; ATP Binding Cassette Transporter, Subfamily G, Member 1; ATP-Binding Cassette Transporters; CD36 Antigens; CHO Cells; Cholesterol Ester Transfer Proteins; Cholesterol Esters; Cholesterol, HDL; Cricetinae; Cricetulus; Drug Therapy, Combination; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Lipoproteins, HDL2; Liver; Macrophages; Male; Mice; Middle Aged; Paris; Particle Size; Postprandial Period; Pyrroles; Quinolines; Time Factors; Transfection; Treatment Outcome | 2012 |
Molecule of the month. Torcetrapib.
Topics: Carrier Proteins; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Clinical Trials as Topic; Glycoproteins; Humans; Hyperlipidemias; Quinolines | 2004 |
Cholesteryl ester transfer protein inhibition and HDL increase: has the dream ended?
Topics: Amides; Blood Pressure; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Drug Design; Drug Therapy, Combination; Esters; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Hypolipidemic Agents; Quinolines; Sulfhydryl Compounds; Up-Regulation | 2008 |